Joe Hernandez, Principal Adviser
Joe Hernandez continues to hold his board and executive position at Principio while providing advice, guidance, and resources to Capital Perception's clients.

He has almost 15 years of executive management, acquisition strategy, and senior marketing development experience. He has served as the President and CEO of Innovative Biosensors, a privately held, venture backed company where he raised over $17.75M from venture capital funds.

Mr. Hernandez also developed and implemented several tactical marketing plans to grow market presence for pharmaceutical products, including new products. He conducted direct market analysis reviews, developed the product positioning strategy, and recommended a strategic advertising campaign to establish a market presence for the company’s core technology.

Mr. Hernandez has developed, led, and executed business development initiatives to increase market penetration for a life science company's business units. He is also responsible for growing another company’s medical technology business unit over 300% under a strategic plan he developed and implemented. He has also spearheaded several key technology acquisition and development initiatives.

In 2003, Mr. Hernandez founded Innovative Biosensors, a company developing novel technologies for the rapid detection of pathogens. Innovative Biosensors' proprietary technology allows for detection of pathogens at previously unseen levels of speed and sensitivity. He developed and refined this technology over the past eight years by leveraging $26M of Department of Defense sponsored development at MIT's Lincoln Labs. This technology is expected to have broad applications in food testing, bio-defense, animal health, and human health care. Innovative Biosensors has received the Incubator Company of the Year Award, The Frost and Sullivan's Technology Leadership Award, and The Innovator of the Year Award.

Mr. Hernandez has published articles in The Journal of Neuroscience, The Journal of Neurobiology, and The Journal of Virology.


Deal Summary

  • Raised $17.25M in venture capital
  • Secured $1.6M Department of Defense contract
  • Negotiated license agreement with MIT


  • University of Florida
    MBA, Finance and Entrepreneurship
  • University of Florida
    MS, Molecular Genetics and Microbiology
  • University of Florida
    BS, Neuroscience

Prior Roles

  • CEO, Principio
  • President & CEO, Innovative BioSensors
  • Senior Manager, Digene
  • Product Manager, Affymetrix